Literature DB >> 9500642

Late fatal adenovirus pneumonitis in a lung transplant recipient.

A Simsir1, E Greenebaum, G Nuovo, L L Schulman.   

Abstract

Adenovirus (ADV) is increasingly recognized as a cause of morbidity and mortality in transplant recipients, but ADV pneumonitis has rarely been reported after lung transplantation. The few reported instances of ADV pneumonitis occurred mostly in children immediately after lung transplantation suggesting "primary" infection. We report a fatal case of ADV pneumonitis occurring in an adult, 4 years after unilateral lung transplantation, in whom the premortem diagnosis was not determined. Autopsy revealed severe necrotizing bronchitis, bronchiolitis, and interstitial pneumonitis. Characteristic smudgy intranuclear inclusions, immunohistochemistry for viral protein, in situ hybridization for viral genome, and postmortem lung cultures established ADV as the etiologic agent. ADV can cause fatal, occult respiratory infection in adult lung transplant recipients, remote from transplant surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9500642     DOI: 10.1097/00007890-199802270-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

3.  Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation.

Authors:  Lara A Danziger-Isakov; Sarah Worley; Susana Arrigain; Paul Aurora; Manfred Ballmann; Debra Boyer; Carol Conrad; Irmgard Eichler; Okan Elidemir; Samuel Goldfarb; George B Mallory; Marian G Michaels; Peter Michelson; Peter J Mogayzel; Daiva Parakininkas; Melinda Solomon; Gary Visner; Stuart Sweet; Albert Faro
Journal:  J Heart Lung Transplant       Date:  2008-04-24       Impact factor: 10.247

4.  Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia.

Authors:  Se Jin Kim; Kang Kim; Sung Bum Park; Duck Jin Hong; Byung Woo Jhun
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

5.  Characteristics of Adenovirus Pneumonia in Korean Military Personnel, 2012-2016.

Authors:  Hee Yoon; Byung Woo Jhun; Hojoong Kim; Hongseok Yoo; Sung Bum Park
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

Review 6.  Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.

Authors:  Joseph P Lynch; Adriana E Kajon
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

7.  Clinical characteristics and factors predicting respiratory failure in adenovirus pneumonia.

Authors:  Hee Yoon; Byung Woo Jhun; Se Jin Kim; Kang Kim
Journal:  Respirology       Date:  2016-06-15       Impact factor: 6.424

8.  Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance.

Authors:  Atul Humar; Karen Doucette; Deepali Kumar; Xiao-Li Pang; Dale Lien; Kathy Jackson; Jutta Preiksaitis
Journal:  J Heart Lung Transplant       Date:  2006-10-30       Impact factor: 10.247

9.  Comparison of clinical characteristics and inflammatory cytokines between hypoxemic and non-hypoxemic human adenovirus 55 pneumonia.

Authors:  Jeong Uk Lim; Joon Young Choi; Ho Jung Jeong; Jae-Hoon Ko; Ji Eun Lee; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.